Thursday June 2, 2016 0 comments
LONE TREE -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, today announced it has hired Rick Luckenbill as VP of finance.
Paul Oberman, interim CFO consultant since October 2015, will still be available for the company on an as-needed basis, Zynex said.
Luckenbill has more than 20 years experience in multiple industries with proven leadership in finance, accounting and system integration roles. His work experience includes debt restructure, cash flow optimization, profitability improvement and system integration.
Prior to joining Zynex, Luckenbill served as CFO/VP of finance with CPP, Inc., an engineering consulting business in Fort Collins. He has also served in various accounting roles with Medtronic, Inc., Thermo Fisher Scientific, Inc., Omnitrax, Inc. and Motorola, Inc. and as director of systems integration with Motorola Solutions, Inc.
Luckenbill holds an MBA in finance from the Keller Graduate School of Management of DeVry University, Scottsdale, AZ and a BS, Finance/Organizational Development, Elmhurst College, Elmhurst, IL.
"I am excited to have added Rick Luckenbill to the organization as our permanent leader of our accounting and finance functions,” said Thomas Sandgaard, Zynex CEO.
“Rick's experience in the high-tech and medical device industries is a great asset as well as his experience with both large and smaller organizations. The landscape in our core market of home electrotherapy devices has significantly changed over the past year and Zynex is quickly becoming a market leader in this segment growing fast towards the levels we experienced in 2012 and beyond."
Founded in 1996, Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation and its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.
Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers.